Merck Animal Health announces that Arovyn (tulathromycin injection) is now available to veterinarians prescribing tulathromycin, which is used to control and treat bovine respiratory disease (BRD), plus treat foot rot and pinkeye. The prescription antibiotic, recently approved by the FDA, is the latest addition to the comprehensive antimicrobial portfolio and BRD solutions from Merck Animal Health.
“Arovyn offers veterinarians and producers a new, cost-effective option for tulathromycin,” said David Sjeklocha, D.V.M., technical services manager for Merck Animal Health. “On-label to administer on arrival with high-risk cattle, Arovyn also can be used to treat BRD, foot rot and pinkeye – all of which are common and costly diseases.”
In beef and non-lactating dairy cattle, Arovyn is indicated for the treatment of BRD and control of respiratory disease in animals at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis. It also is approved for treatment of pinkeye or infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis, plus treatment of foot rot associated with Fusobacterium necrophorum and Porphyromonas levii. In suckling calves, dairy calves and veal calves, Arovyn is indicated for treatment of BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
“Arovyn is backed by Merck Animal Health’s technical service and sales team with extensive expertise in managing BRD, cattle health and well-being,” explained Dr. Sjeklocha. “In addition to Arovyn, Merck Animal Health has introduced several products within the past two years to help producers manage BRD, including a first-of-its-kind intranasal vaccine Bovilis Nasalgen 3-PMH and two innovative technologies Whisper On Arrival and SenseHub Feedlot to help identify and treat sick cattle sooner.
Arovyn is approved for cattle and swine and comes in 50-, 100-, 250- and 500-mL vials. It is manufactured in the same facility as other Merck Animal Health antimicrobials, such as Zuprevo (tildipirosin), with the same high quality assurance guidelines.